Healthcare AI Acquisition Corp.
HAIA
NASDAQ Global Market10.86
USD
+10.86
- -
Healthcare AI Acquisition Corp.
HAIA
(NASDAQ Global Market)
Recent
price
10.86
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Healthcare AI Acquisition Corp. (NASDAQ: HAIA) operates as a blank check company whose primary business is to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. Incorporated in 2021 and based in George Town, Cayman Islands, with additional references to Dover, Delaware operations, the company focuses on targets in the healthcare and pharmaceutical sectors, including e-clinical solutions, healthcare information technology, and outsourced pharmaceutical services with high AI readiness and technological transformation potential. As a special purpose acquisition company sponsored by affiliates such as Healthcare AI Acquisition, LLC and Atticus Ale, LLC, it holds no significant current operations or products beyond pursuing and executing such combinations. In August 2024, HAIA entered into a definitive Business Combination Agreement with Leading Group Limited and Leading Partners Limited, under which Leading Group—a China-based digital insurance brokerage providing integrated marketing services, digital brokerage, and tailored insurance solutions to carriers, individuals, and corporate policyholders—would become the surviving entity valued at approximately $430 million, with plans for a concurrent $50 million private placement and Nasdaq listing. The transaction, unanimously approved by both boards and structured through Cayman Islands mergers involving newly formed subsidiaries, remains pending shareholder, regulatory, and closing conditions as of late 2025. Most recently, in November 2025, HAIA shareholders approved a month-to-month extension of the business combination deadline from October 14, 2025, to October 14, 2026, with $0.10 monthly deposits per non-redeemed public share into the trust account following modest redemptions; earlier extensions included provisions through May 2025 and additional financing like a $100,000 promissory note from Leading Group. Leadership changes include the appointment of Xiaocheng Peng as permanent CFO and director, with Jiande Chen serving as Chairman and CEO.
Leading Group, an Insurance Channel Specialist in China, to be Publicly Listed through a Merger with Healthcare AI Acquisition Corp. (NASDAQ: HAIA)
Healthcare AI Acquisition Corp. Announces Receipt of Nasdaq Deficiency Letter
Healthcare AI Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination